Daily Stock Opinions and Ratings

Opinions

The Weekly Buzzing Stocks by Billy KawasakiTilray Inc.TLRYTOP PICKOct 07, 2021

The medical marijuana space is looking good according to Larry Berman. Legalization is expanding in the US. There will be volatility so sell into strength. Social media mentions have increased 7% in the past 24 hours.

The Weekly Buzzing Stocks by Billy Kawasaki

Unknown

$11.16

Stock price when the opinion was issued

$4.74

As of Jun 18, 2026. Market Open.

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY ON WEAKNESS

Bottoming process a good place to buy for investors. Would wait a bit before investing. Not much momentum in company.

WATCH

Are diversifying away from cannabis into alcohol which diversifies their revenues. They bought Hexo. Interesting company. Also, they hold a lot of cash which will allow them buying more companies.

DON'T BUY

In past years, executives were lavishly compensated. He owns no cannabis stocks. Have been hopes that the Democrats will decriminalize cannabis and is unlikely to happen. So, these businesses are stuck in no-man's land. For instance, they can't deduct rent from expenses, or can't get bank loans.

DON'T BUY

Remember, it's a small cap so can be volatile. In the past two months, it's failing to break out. He's cool towards it.

DON'T BUY

Too speculative and it's losing money.

SELL

Death spiral. The hype was crazy. None of these companies is going to make any money. Sell it, take the loss, move on. No chance for a rebound.

BUY

A smart move to get into beer by buying some brands. True, they are losing money, but this and Canopy are the best in this space.

COMMENT

It reports Friday. He expects them to make a bold announcement about the U.S. legalization of cannabis. Shares are so low. For once, this could be a decent spec buy.

DON'T BUY

It reports Monday. Pot stocks have been devastating. Since 2018, this has been all downhill. Let's see if the CEO can change direction.

BUY ON WEAKNESS

Bullish on medical marijuana. We will see legalizing banking in the US for the sector. There will be volatility. He sold into strength. Likes it here. Has lots of upside potential.

COMMENT

It will be a big industry that will be huge in the future. There is still 30%-50% upside in the future. The question should be whether you would add new money or not. If you do not want to , it is time to cash out.

DON'T BUY

There's lower highs and lower lows. He would look elsewhere for better potential.

DON'T BUY

He would not buy this. It collapsed from $350. Not the story he invests in. A long term story, hopefully with another couple years of losses yet to come. Too risky for him.

COMMENT

There is some downside pressure on HMMJ-T. At the $14 or $17 range there is resistance. Who knows what the effect would be if the government changes in October. [Caller asked about TLRY] He sees $34 as a target on TLRY-T as there is nothing to hold it higher.

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.